NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.71−0.04 (-5.15%)
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Neuroone Medical Technologies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Neuroone Medical Technologies's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.05M. For fiscal 2025 it was -$2.84M. The highest annual figure on record is -$5.09K in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$2.84M | – |
| FY2024 | Sep 30, 2024 | -$11.01M | – |
| FY2023 | Sep 30, 2023 | -$12.89M | – |
| FY2022 | Sep 30, 2022 | -$7.52M | – |
| FY2021 | Sep 30, 2021 | -$8.60M | – |
| FY2020 | Sep 30, 2020 | -$3.43M | – |
| FY2017 | Dec 31, 2017 | -$2.11M | – |
| FY2016 | Dec 31, 2016 | -$21.11K | – |
| FY2015 | Dec 31, 2015 | -$30.23K | – |
| FY2014 | Dec 31, 2014 | -$26.17K | – |
| FY2013 | Dec 31, 2013 | -$25.09K | – |
| FY2012 | Dec 31, 2012 | -$13.73K | – |
| FY2011 | Dec 31, 2011 | -$27.43K | – |
| FY2010 | Dec 31, 2010 | -$5.09K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$1.08M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$1.33M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$3.12M | -1597.6% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$1.53M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.46M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$56.14K | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $208.05K | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$2.67M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$2.36M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$2.18M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$3.81M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$2.90M | -385.2% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$2.94M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$3.55M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$3.49M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $1.02M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.64M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$3.22M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$2.68M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$2.03M | -844.2% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$2.29M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.38M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$1.90M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $272.67K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.22M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.25M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$1.22M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -$598.40K | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$596.50K | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -$562.25K | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | -$350.92K | – |
| Q4 FY2016CQ4 2016 | Dec 31, 2016 | -$7.33K | – |
| Q3 FY2016CQ3 2016 | Sep 30, 2016 | -$5.57K | – |
| Q2 FY2016CQ2 2016 | Jun 30, 2016 | -$8.21K | – |
| Q1 FY2016CQ1 2016 | Mar 31, 2016 | $0 | – |
| Q4 FY2015CQ4 2015 | Dec 31, 2015 | -$6.35K | – |
| Q3 FY2015CQ3 2015 | Sep 30, 2015 | -$3.25K | – |
| Q2 FY2015CQ2 2015 | Jun 30, 2015 | -$1.03K | – |
| Q1 FY2015CQ1 2015 | Mar 31, 2015 | -$19.59K | – |
| Q4 FY2014CQ4 2014 | Dec 31, 2014 | -$9.03K | – |
See a number that looks wrong?